Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARX | CGON | PTGX | ||
| Company | Ra Pharmaceuticals Inc | Cg Oncology Inc | Protagonist Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.99 | 30.70 | 37.25 | ||
| High | 48.01 | 30.70 | 37.25 | ||
| Low | 47.98 | 30.70 | 37.25 | ||
| Last | 48.00 | 30.37 | 37.40 | ||
| Change | -0.02 | -0.09 | -0.22 | ||
| % Change | -0.03% | -0.30% | -0.58% | ||
| Volume | 3,864,600 | 529 | 604 | ||
| 20-Day Average Volume | 1,869,975 | 959,656 | 642,145 | ||
| Previous Close | 48.01 | 30.46 | 37.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.03 | 29.36 | 39.51 | ||
| 20-Day Raw Stochastic | 99.68% | 66.97% | 5.72% | ||
| 20-Day Relative Strength | 56.47% | 47.38% | 38.94% | ||
| Weighted Alpha | +21.70 | -15.47 | +26.70 | ||
| Today's Opinion | 56% Buy | 72% Sell | 40% Sell | ||
| Previous Opinion | 56% Buy | 72% Sell | 40% Sell | ||
| Last Month's Opinion | 80% Buy | 72% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.91% since 03/25/20 | +5.97% since 01/02/25 | -4.44% since 01/02/25 | ||
| Low | 46.34 on 03/26/20 | 28.72 on 01/03/25 | 36.95 on 01/08/25 | ||
| High | 48.02 on 03/31/20 | 32.11 on 01/07/25 | 40.16 on 01/03/25 | ||
| 1-Month | |||||
| %Chg | +2.64% since 02/28/20 | -8.90% since 12/10/24 | -10.46% since 12/10/24 | ||
| Low | 40.30 on 03/18/20 | 27.00 on 12/19/24 | 36.95 on 01/08/25 | ||
| High | 48.02 on 03/31/20 | 32.53 on 12/11/24 | 42.19 on 12/11/24 | ||
| 3-Month | |||||
| %Chg | +2.27% since 12/31/19 | -10.96% since 10/10/24 | -14.54% since 10/10/24 | ||
| Low | 40.30 on 03/18/20 | 27.00 on 12/19/24 | 33.31 on 11/19/24 | ||
| High | 48.02 on 03/31/20 | 40.47 on 11/11/24 | 48.89 on 10/28/24 | ||
| 6-Month | |||||
| %Chg | +112.27% since 10/01/19 | -6.43% since 07/10/24 | +7.10% since 07/10/24 | ||
| Low | 22.25 on 10/08/19 | 27.00 on 12/19/24 | 32.50 on 08/05/24 | ||
| High | 48.02 on 03/31/20 | 40.47 on 11/11/24 | 48.89 on 10/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,271,555 | 2,316,118 | 2,242,076 | ||
| Shares Outstanding, K | 47,329 | 76,038 | 59,598 | ||
| Annual Sales | 3,000,000 | 200,000 | 60,000,000 | ||
| Annual Net Income | -102,690,000 | -48,610,000 | -78,960,000 | ||
| Last Quarter Sales | 3,000,000 | 40,000 | 4,680,000 | ||
| Last Quarter Net Income | -24,980,000 | -20,410,000 | -33,210,000 | ||
| 60-Month Beta | 1.04 | N/A | 2.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.30 on 11/12/24 | -0.54 on 11/07/24 | ||
| Latest Earnings Date | 05/14/20 | 11/14/24 | 02/25/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 14.45 | ||